Levels of alpha-toxin correlate with distinct phenotypic response profiles of blood mononuclear cells and with agr background of community-associated Staphylococcus aureus isolates

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Shambat, Srikanth Mairpady ^a   Haggar, Axana ^a   Vandenesch, Francois ^b   Lina, Gerard ^b   Van Wamel, Willem J B ^c   Arakere, Gayathri ^d   Svensson, Mattias ^a   Norrby Teglund, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; IMMUNOGLOBULIN; PANTON VALENTINE LEUKOCIDIN; BACTERIAL TOXIN; SUPERANTIGEN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; SUPERNATANT; BLOOD; CLASSIFICATION; COMMUNITY ACQUIRED INFECTION; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; STAPHYLOCOCCUS INFECTION;

BACTERIAL TOXINS; CELL PROLIFERATION; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 84940326139     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106107     Document Type: Article

References (43)

1. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, et al. (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9: 978-984. (Pubitemid 36944519)
2. (1999) Four pediatric deaths from community-acquired methicillin- resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. Morb Mortal Wkly Rep 48: 707-710.
3. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, et al. (2005) Necrotizing fasciitis caused by community-associated methicillin- resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352: 1445-1453. (Pubitemid 40471452)
4. Mediavilla JR, Chen L, Mathema B, Kreiswirth BN (2012) Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CAMRSA). Curr Opin Microbiol 15: 588-595.
5. Strandberg KL, Rotschafer JH, Vetter SM, Buonpane RA, Kranz DM, et al. (2010) Staphylococcal superantigens cause lethal pulmonary disease in rabbits. J Infect Dis 202: 1690-1697.
6. Xu SX, McCormick JK (2012) Staphylococcal superantigens in colonization and disease. Front Cell Infect Microbiol 2: 52.
7. Spaulding AR, Salgado-Pabon W, Kohler PL, Horswill AR, Leung DY, et al. (2013) Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev 26: 422-447.
8. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O (2007) Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13: 1405-1406. (Pubitemid 350224232)
9. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359: 753-759. (Pubitemid 34215075)
10. Vandenesch F, Lina G, Henry T (2012) Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol 2: 12.
11. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, et al. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13: 1510-1514. (Pubitemid 350224240)
12. Deghorain M, Van Melderen L (2012) The Staphylococci phages family: an overview. Viruses 4: 3316-3335.
13. Malachowa N, DeLeo FR (2010) Mobile genetic elements of Staphylococcus aureus. Cell Mol Life Sci 67: 3057-3071.
14. Foster TJ (2005) Immune evasion by staphylococci. Nat Rev Microbiol 3: 948-958.
15. Ji G, Beavis R, Novick RP (1997) Bacterial interference caused by autoinducing peptide variants. Science 276: 2027-2030. (Pubitemid 27443604)
16. Lindsay JA, Holden MT (2004) Staphylococcus aureus: superbug, super genome? Trends Microbiol 12: 378-385. (Pubitemid 38987825)
17. Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48: 1429-1449.
18. Jarraud S, Lyon GJ, Figueiredo AM, Lina G, Vandenesch F, et al. (2000) Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J Bacteriol 182: 6517-6522.
19. Geisinger E, Chen J, Novick RP (2012) Allele-dependent differences in quorum-sensing dynamics result in variant expression of virulence genes in Staphylococcus aureus. J Bacteriol 194: 2854-2864.
20. Croze M, Dauwalder O, Dumitrescu O, Badiou C, Gillet Y, et al. (2009) Serum antibodies against Panton-Valentine leukocidin in a normal population and during Staphylococcus aureus infection. Clin Microbiol Infect 15: 144-148.
21. Jacobsson G, Colque-Navarro P, Gustafsson E, Andersson R, Mollby R (2010) Antibody responses in patients with invasive Staphylococcus aureus infections. Eur J Clin Microbiol Infect Dis 29: 715-725.
22. Kanclerski K, Soderquist B, Kjellgren M, Holmberg H, Mollby R (1996) Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia. J Med Microbiol 44: 171-177. (Pubitemid 26103230)
23. Ide F, Matsubara T, Kaneko M, Ichiyama T, Mukouyama T, et al. (2004) Staphylococcal enterotoxin-specific IgE antibodies in atopic dermatitis. Pediat Int 46: 337-341. (Pubitemid 38756974)
24. Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, et al. (2010) Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis 50: 61-68.
25. Brosnahan AJ, Mantz MJ, Squier CA, Peterson ML, Schlievert PM (2009) Cytolysins augment superantigen penetration of stratified mucosa. J Immunol 182: 2364-2373.
26. Shambat S, Nadig S, Prabhakara S, Bes M, Etienne J, et al. (2012) Clonal complexes and virulence factors of Staphylococcus aureus from several cities in India. BMC Microbiol 12: 64.
27. Arnaud M, Chastanet A, Debarbouille M (2004) New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microbiol 70: 6887-6891. (Pubitemid 39518603)
28. Boisset S, Geissmann T, Huntzinger E, Fechter P, Bendridi N, et al. (2007) Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism. Genes Dev 21: 1353-1366. (Pubitemid 46871039)
29. Hansenova Manaskova S, Bikker FJ, Veerman EC, van Belkum A, van Wamel WJ (2013) Rapid detection and semi-quantification of IgG-accessible Staphylococcus aureus surface-associated antigens using a multiplex competitive Luminex assay. J Immunol Methods.
30. Badiou C, Dumitrescu O, Croze M, Gillet Y, Dohin B, et al. (2008) Panton-Valentine leukocidin is expressed at toxic levels in human skin abscesses. Clin Microbiol Infect 14: 1180-1183.
31. Rasigade JP, Trouillet-Assant S, Ferry T, Diep BA, Sapin A, et al. (2013) PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. PLoS One 8: e63176.
32. Spaan AN, Henry T, van Rooijen WJ, Perret M, Badiou C, et al. (2013) The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. Cell Host Microbe 13: 584-594.
33. Darenberg J, Soderquist B, Normark BH, Norrby-Teglund A (2004) Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis 38: 836-842. (Pubitemid 38387232)
34. Farag N, Mahran L, Abou-Aisha K, El-Azizi M (2013) Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo. Eur J Clin Microbiol Infect Dis 32: 1149-1160.
35. Nishi JI, Kanekura S, Takei S, Kitajima I, Nakajima T, et al. (1997) B cell epitope mapping of the bacterial superantigen staphylococcal enterotoxin B: the dominant epitope region recognized by intravenous IgG. J Immunol 158: 247-254. (Pubitemid 127483862)
36. Takei S, Arora YK, Walker SM (1993) Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 91: 602-607. (Pubitemid 23064146)
37. Gauduchon V, Cozon G, Vandenesch F, Genestier AL, Eyssade N, et al. (2004) Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 189: 346-353. (Pubitemid 38147260)
38. Alonzo F 3rd, Kozhaya L, Rawlings SA, Reyes-Robles T, DuMont AL, et al. (2013) CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493: 51-55.
39. DuMont AL, Torres VJ (2014) Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids. Trends Microbiol 22: 21-27.
40. Novick RP, Geisinger E (2008) Quorum sensing in staphylococci. Annu Rev Genet 42: 541-564.
41. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, et al. (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70: 631-641. (Pubitemid 34083822)
42. Collery MM, Smyth DS, Twohig JM, Shore AC, Coleman DC, et al. (2008) Molecular typing of nasal carriage isolates of Staphylococcus aureus from an Irish university student population based on toxin gene PCR, agr locus types and multiple locus, variable number tandem repeat analysis. J Med Microbiol 57: 348-358. (Pubitemid 351358539)
43. Szkaradkiewicz A, Karpinski TM, Zeidler A, Szkaradkiewicz AK, Masiuk H, et al. (2012) Cytokine response in patients with chronic infections caused by Staphylococcus aureus strains and diversification of their Agr system classes. Eur J Clin Microbiol Infect Dis 31: 2809-2815.